Cary J. Retterer

发表

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

William A. Lee, Mike Flint, Donald K. Nichols, 2016, Nature.

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

Gianluca Pegoraro, Sina Bavari, Travis K. Warren, 2014, Nature.

Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.

S. Bavari, R. Panchal, B. Vasiljević, 2019, European journal of medicinal chemistry.

Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.

Steven B. Bradfute, J. Kuhn, S. Radoshitzky, 2011, Journal of virological methods.

Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase

S. Bavari, C. Whitehouse, Cary J. Retterer, 2016, PLoS pathogens.

Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1

John A. Young, K. Kehn-Hall, B. Ling, 2017, Journal of Virology.

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor

S. Bavari, R. Panchal, J. Burnett, 2012, Viruses.

Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors.

J. Dye, J. Kuhn, S. Radoshitzky, 2018, Cell host & microbe.

IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus

J. Kuhn, S. Radoshitzky, M. Farzan, 2013, Journal of Virology.

Ebolavirus (cid:1) -Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry (cid:1)

Steven B. Bradfute, P. J. Kranzusch, J. Cunningham, 2011 .

Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques.

T. Bell, C. Cooper, S. Bavari, 2015, Viral immunology.

Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison

M. Ward, L. Cazares, R. Norgren, 2019, Clinical Proteomics.

Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors

G. Ruthel, S. Sandwick, S. Bavari, 2011, Toxins.

Machupo Virus Glycoprotein Determinants for Human Transferrin Receptor 1 Binding and Cell Entry

J. Kuhn, S. Radoshitzky, S. Bavari, 2011, PloS one.

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

Stanley N Cohen, R. Clubb, S. Bavari, 2015, Scientific Reports.

High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection

S. Bavari, R. Panchal, Cary J. Retterer, 2012, Viruses.

Alkylated Porphyrins Have Broad Antiviral Activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses

F. Krebs, S. Bavari, B. Wigdahl, 2010, Antimicrobial Agents and Chemotherapy.

Identification of a coumarin‐based antihistamine‐like small molecule as an anti‐filoviral entry inhibitor

S. Bavari, Lijun Rong, N. Peet, 2017, Antiviral research.

HSPA5 is an essential host factor for Ebola virus infection.

K. Spurgers, S. Bavari, S. Reid, 2014, Antiviral research.

Ebolavirus Δ-Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry

Steven B. Bradfute, P. J. Kranzusch, J. Cunningham, 2011, Journal of Virology.

Multi-Faceted Proteomic Characterization of Host Protein Complement of Rift Valley Fever Virus Virions and Identification of Specific Heat Shock Proteins, Including HSP90, as Important Viral Host Factors

Brian D. Peyser, K. Kehn-Hall, S. Bavari, 2014, PloS one.

Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin

G. Ruthel, P. J. Kranzusch, S. Whelan, 2010, Journal of Virology.

Repurposing potential of 1st generation H1‐specific antihistamines as anti‐filovirus therapeutics

G. Thatcher, S. Bavari, Lijun Rong, 2018, Antiviral research.

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

Stanley N Cohen, R. Clubb, S. Bavari, 2015, Scientific Reports.

Strategies for Validation of Inactivation of Viruses with Trizol® LS and Formalin Solutions

Tara A. Kenny, S. Coyne, Cary J. Retterer, 2020, Applied biosafety : journal of the American Biological Safety Association.

High Content Image-Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Rift Valley Fever Virus and Other Highly Pathogenic RNA Viruses

S. Bavari, C. Whitehouse, Cary J. Retterer, 2014, PLoS neglected tropical diseases.

Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison

M. Ward, L. Cazares, R. Norgren, 2019, Clinical Proteomics.

High-Content Image–Based Screening of a Signal Transduction Pathway Inhibitor Small-Molecule Library against Highly Pathogenic RNA Viruses

S. Bavari, C. Whitehouse, Cary J. Retterer, 2015, Journal of biomolecular screening.

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

William A. Lee, Jeffrey R. Kugelman, G. Palacios, 2016, Nature.

Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.

S. Radoshitzky, J. Shiver, S. Bavari, 2019, Antiviral research.

Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

Stanley N Cohen, R. Clubb, S. Bavari, 2015, Scientific Reports.

IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus

J. Kuhn, S. Radoshitzky, M. Farzan, 2013, Journal of Virology.

Ebolavirus Δ-Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry

Steven B. Bradfute, J. Cunningham, V. Volchkov, 2011, Journal of Virology.